Cargando…
Genomic Profiling of Sarcomas: A Promising Weapon in the Therapeutic Arsenal
Sarcomas are rare malignant mesenchymal neoplasms, and the knowledge of tumor biology and genomics is scarce. Chemotherapy is the standard of care in advanced disease, with poor outcomes. Identifying actionable genomic alterations may offer effective salvage therapeutic options when previous lines h...
Autores principales: | Lopes-Brás, Raquel, Lopez-Presa, Dolores, Esperança-Martins, Miguel, Melo-Alvim, Cecília, Gallego, Lina, Costa, Luís, Fernandes, Isabel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693140/ https://www.ncbi.nlm.nih.gov/pubmed/36430703 http://dx.doi.org/10.3390/ijms232214227 |
Ejemplares similares
-
Management of Unresectable Localized Pelvic Bone Sarcomas: Current Practice and Future Perspectives
por: Soares do Brito, Joaquim, et al.
Publicado: (2022) -
Osteosarcoma Pathogenesis Leads the Way to New Target Treatments
por: Fernandes, Isabel, et al.
Publicado: (2021) -
Phytochemicals: A Promising Weapon in the Arsenal against Antibiotic-Resistant Bacteria
por: Khameneh, Bahman, et al.
Publicado: (2021) -
Breast Sarcomas, Phyllodes Tumors, and Desmoid Tumors: Turning the Magnifying Glass on Rare and Aggressive Entities
por: Esperança-Martins, Miguel, et al.
Publicado: (2023) -
HMGB1: The metabolic weapon in the arsenal of NK cells
por: Cerwenka, Adelheid, et al.
Publicado: (2016)